Best quantum computing stocks to buy from India (June 2026): pure-plays, mega-caps, ETFs

Two structural events in the 48 hours before this article publishes:

June 1–2, 2026: Quantinuum — Honeywell's trapped-ion quantum unit, formed from the November 2021 merger of Honeywell Quantum Solutions and Cambridge Quantum — upsized its IPO to $53–55/share, 26.5 million shares, raising up to ~$1.46 billion at a valuation of up to $14.3 billion. Honeywell will retain ~49.1% voting power; combined founder ownership ~82% post-IPO. Honeywell will deconsolidate Quantinuum in Q2 2026.

June 2, 2026: Microsoft announced Majorana 2 — the topological qubit chip stack with aluminum replaced by lead in the superconducting layer. >2× topological gap, ~1,000× reliability improvement versus Majorana 1, mean qubit lifetime 20 seconds (some instances up to 1 minute). And the line that moved the market: Microsoft now expects a scalable quantum computer by 2029 — timeline pulled in from the late-2030s.

Both inside 48 hours. Both before the most speculative thematic guide of 2026 reaches its readers.

Now the honest number that should anchor everything else: the four public pure-play quantum computing companies — IonQ, Rigetti, D-Wave, and Quantum Computing Inc. — did ~$76 million of revenue combined in Q1 2026. That is roughly 0.5% of NVIDIA's Q1 data-center revenue alone. Their aggregate market capitalization is north of $40 billion. The most credible quantum exposures sit inside mega-caps (IBM, Google, Microsoft, Amazon, NVIDIA) where quantum is less than 1% of revenue — meaning if you buy them "for quantum," you are buying everything else first.

This guide is for the Indian-resident investor who wants honest framing on a category where the press releases run ahead of the audited numbers. The answer for most readers, after reading the data: own NVDA + MSFT + GOOG + AMZN + IBM as part of a normal mega-cap allocation, get the quantum optionality for free, revisit in 2028 when there's data to argue about.

What this guide is and isn't

It is: 25 names organized by what's actually investable, one verdict per name, three positioning options (including "pass entirely"), and explicit calls on names with misleading "quantum" branding.

It is not: a quantum-maximalist thesis. Not a "buy these four pure-plays" recommendation. Not pretending that public-pure-play quantum is the same as private-leader-quantum (it isn't — the actual leaders are mostly private).

A note on data. Every revenue, cash position, qubit-count, customer disclosure, and tax-credit detail traces to a primary source — SEC filings, Q1 2026 earnings calls, peer-reviewed Nature papers (Google Willow, Quantum Echoes), official Microsoft / IBM / NVIDIA disclosures, Bloomberg IPO terms. Where verification was not possible, the article says so. The semiconductor guide's sources companion established the format; the same standard applies.

The framework: pre-revenue + mega-cap dilution + architecture risk

Three reasons quantum is structurally different from the other four thematic guides:

Pre-revenue. The combined Q1 2026 revenue of all four public pure-plays (IONQ $64.7M + RGTI $4.4M + QBTS $2.9M + QUBT $3.7M = $75.7M) reflects mostly government/research contracts and lumpy system sales. The "valuation per revenue dollar" question is uniquely brutal in this category — IonQ trades at ~57× FY26e EV/sales using the company's raised $260–270M guide; D-Wave trades at ~200× FY26e EV/sales with revenue down 81% YoY but bookings up 2,000%.

Mega-cap dilution. Quantum revenue as % of total revenue, June 2026:

IBM: <0.5% of $63B revenue
GOOG: <0.1% of $354B revenue
MSFT: <0.05% of $260B revenue
AMZN: <0.01% of $640B revenue
NVDA: 0% (CUDA-Q is free software; no hardware revenue)
HON (pre-Q2 2026 deconsolidation): ~1–2% via Quantinuum — the only mega-cap where quantum is non-trivial, and it ends with Q2 deconsolidation

Architecture risk. Seven competing architectures (superconducting, trapped-ion, photonic, neutral-atom, annealing, topological, silicon-spin) are racing toward fault tolerance. One or more may not get there. A concentrated single-name bet is implicitly a bet on one architecture.

The structural caveat: the actual quantum leaders are mostly private until the Quantinuum IPO closes this month. PsiQuantum (~$7B post-money, BlackRock-led $1B September 2025 Series E). QuEra (Google strategic investor; DARPA QBI Stage B). Atom Computing (Microsoft Azure partner; first to cross 1,000 qubits; DARPA QBI Stage B). The public pure-play universe is structurally missing the front-runners.

Six layers, ranked by how clearly investable each is for Indian retail today:

Layer	What it is	2026 read
1. Public pure-plays	IONQ, RGTI, QBTS, QUBT, ARQQ, LAES	All pre-revenue; high volatility; architecture-bet
2. Mega-cap embedded	IBM, GOOG, MSFT, AMZN, NVDA, INTC, HON (pre-deconsolidation)	Real R&D, irrelevant to multiple
3. Picks-and-shovels	FORM, MKSI, COHR, LITE, POET	Quantum is single-digit % of revenue
4. Private leaders	PsiQuantum, QuEra, Atom Computing, Pasqal, Quantinuum (IPO this month)	Not accessible until IPO
5. Quantum-themed ETF	QTUM	Mostly semi + ML, not pure quantum
6. Misleading branding	QSI (protein sequencing), IIVI (delisted)	Don't include

Verdict format:

Verdict — [Action]: [The reason in one line]. [The caveat in one line].

Actions: Core buy (full position), Add (build into it), Hold (own but don't add), Watch (waiting for entry), Hedge (small position as risk offset), Skip (multiple does not compensate), Avoid (structurally damaged or wrong wrapper), Pass (the entire category isn't your trade).

Layer 1 — Public pure-play quantum companies

IONQ — IonQ, Inc.

Architecture: Trapped-ion (augmented by Oxford Ionics' surface electrode trap IP post-September 2025).

Q1 2026 (reported May 6, 2026): revenue $64.7M (+755% YoY) — 30% above midpoint of prior guide. Adjusted EBITDA loss $96.8M. Adjusted EPS −$0.34 (beat consensus −$0.46/−$0.52). GAAP net income $805.4M (driven by non-cash warrant valuation gains — ignore for run-rate). Cash + investments $3.1 billion (best-funded pure-play by a wide margin). Remaining Performance Obligations $470 million (+554% YoY). FY 2026 guide raised to $260–270 million revenue.

Acquisitions completed 2025: Oxford Ionics closed September 17, 2025 for $1.075 billion (~$1.065B in IonQ shares + ~$10M cash); ID Quantique controlling stake closed May 6, 2025 (~300 networking patents, SK Telecom partnership); Lightsynq Harvard spinout closed June 2025 (~20 patents, photonic interconnects + quantum memory; 12.38M IONQ shares issued); Capella Space mid-2025 (satellite QKD infrastructure); Qubitekk 2025 (118 networking patents). Combined patent portfolio now >900.

Hardware: Tempo system targeting 100 qubits; achieved #AQ 64 (IonQ's proprietary algorithmic-qubit benchmark) three months ahead of schedule — only company at #AQ 64 disclosed. Two-qubit gate fidelity 99.99% in R&D prototypes; basis for 256-qubit systems planned 2026 demonstrations. Long-term target 2 million qubits by 2030 (aspirational). Forte Enterprise is the currently-shipping commercial system used by AWS, AstraZeneca, NVIDIA collaborations.

Customer disclosures: AFRL $54.5 million networking design contract + $21.1 million drone free-space optical link; DOE/Oak Ridge energy applications; DARPA QBI Stage A selected, advanced to Stage B (November 2025 cohort). Commercial revenue mix Q1 2026: ~60% commercial, ~35% international.

EV/Sales FY26e (using $265M midpoint, ~$15B EV at $50/share): ~57×.

Catalyst: 256-qubit system demonstration; Tempo full launch; Oxford Ionics integration milestones; further DARPA QBI Stage B funding draws.

Risk: Highest valuation in the cohort versus revenue base; #AQ 64 is proprietary and not peer-reviewed; multiple stock-based acquisitions create significant share-count dilution (fully-diluted share count is ~50% higher than pre-2025); trapped-ion gate speeds remain ~1000× slower than superconducting (offset by higher fidelity).

Verdict — Hedge: The best-funded and most-acquisitive public pure-play, with a real DARPA Stage B credential and a credible commercial mix. Multiple is the issue. Size 0.5–1% maximum.

RGTI — Rigetti Computing

Architecture: Superconducting transmon qubits.

Q1 2026: revenue $4.4 million (+~193% YoY) driven by Novera QPU deliveries + government/research contracts. Operating loss $26.0 million. Non-GAAP EPS −$0.04 (vs −$0.05 PY). Cash + investments ~$569 million; no debt.

Hardware: Ankaa-3 — 84 qubits, 99.5% median two-qubit gate fidelity (publicly launched December 23, 2024). Cepheus-1-108Q — 108-qubit system, GA timing pushed to end of Q1 2026, currently 99.1% median two-qubit gate fidelity, ~60ns gate speed, 99.9% single-gate fidelity. Lyra — 336-qubit modular multi-chip planned late 2026; targets 99.7% two-qubit fidelity.

Customer disclosures: AFRL $5.8 million contract for three-year superconducting quantum networking project. Quanta Computer (Taiwan) strategic partnership signed Feb 27, 2025: $35M PIPE + each side committing $100M+ over 5 years (>$200M combined). Novera QPU on-prem systems delivered to government/research customers (~$5.7M aggregate purchase orders disclosed 2025).

Critical DARPA QBI signal — Rigetti is NOT in the Stage B November 2025 cohort. The 11 companies advancing per the DARPA disclosure: Atom Computing, Diraq, IBM, IonQ, Nord Quantique, Photonic Inc., Quantinuum, Quantum Motion, QuEra Computing, Silicon Quantum Computing, Xanadu. Confidence: High.

EV/Sales FY26e: with ~$30M FY26e revenue and ~$3–4 billion market cap → ~100–130×.

Catalyst: Cepheus-1-108Q GA; Lyra 336-qubit demonstration; AFRL networking deliverables; Quanta partnership commercialization.

Risk: Not selected for DARPA QBI Stage B while peers advanced. Superconducting architecture requires expensive cryogenic infrastructure (dilution refrigerators ~$1M/system). Gate fidelity behind Google Willow (99.7%) and IBM Heron (>99.7%). Revenue base tiny relative to ~$3–4 billion market cap.

Verdict — Skip: The DARPA QBI Stage B exclusion is the unambiguous relative-positioning signal. Better-funded peers with the same architecture exist (IBM, Google).

QBTS — D-Wave Quantum

Architecture: Quantum annealing — NOT gate-model. Advantage2 uses superconducting qubits in an annealing topology; does not chase fault-tolerant gate-model.

Q1 2026 (reported May 12, 2026): revenue $2.9 million (−81% YoY) — fall driven by lumpy comparison versus Q1 2025 (large system sale). Net loss $18.4 million. Gross margin 63.6% GAAP. Bookings record $33.4 million (+~2,000% YoY) — includes $20M Florida Atlantic University Advantage2 system + $10M two-year QCaaS agreement with an unnamed Fortune 100 customer. RPOs $42.4 million. Cash + investments $588 million (+93% YoY) on multiple 2025 ATM/equity offerings.

Hardware: Advantage2 — 4,400+ superconducting qubits in annealing topology; commercially available cloud + on-premises. General availability declared May 2025. >135 cumulative customers; >70 commercial; 24+ Forbes Global 2000 names.

Customers: Japan Tobacco (drug discovery), Los Alamos National Lab (national security), Mastercard (fraud), various optimization deployments in logistics/portfolio optimization.

EV/Sales FY26e: with ~$20–25 million FY26e revenue and ~$5 billion market cap → ~200×. The richest of any quantum pure-play on a forward revenue basis.

Catalyst: Convert $33.4 million Q1 bookings to revenue; incremental system sales; expansion of Fortune 100 QCaaS relationship.

Risk: Quantum annealing is contested by academics — debate persists on whether D-Wave systems achieve genuine quantum speedup versus simulated annealing on classical hardware. Architecture cannot run Shor's algorithm; not a candidate for fault-tolerant gate-model quantum. Revenue highly lumpy.

Verdict — Hedge: Real commercial deployments and record bookings, but on a non-gate-model architecture with disputed quantum speedup. The 200× EV/sales caps upside. Size 0.25–0.5% as optimization-application optionality only.

QUBT — Quantum Computing Inc.

Architecture: Photonic (thin-film lithium niobate integrated photonics) + reservoir computing.

Q1 2026: revenue $3.7 million (+~9,387% YoY). Headline number is artificial — acquisition-driven. Organic revenue ~$204,000 (foundry deliveries + NASA R&D subcontract). Non-GAAP EPS −$0.02 (beat consensus −$0.05 by 60%). Cash + investments ~$1.4 billion built via multiple ATM raises through 2025.

Acquisitions: Lumina Semiconductor (LSI) completed Feb 2026, $110 million all-cash from Luminar Technologies (lasers, detectors, advanced packaging, photonic components); NuCrypt LLC completed March 2026, $5 million (quantum communications IP).

Partnerships: POET Technologies co-development of 3.2 Tbps optical engines for CPO and next-gen AI connectivity.

EV/Sales FY26e: at ~$5 billion market cap and FY26e revenue of perhaps $20–30M (post-LSI full quarters), → ~150–200×.

Risk: Heaviest use of ATM dilution in the cohort 2024–25; organic quantum revenue still <$1M/quarter; "quantum" branding overlaps with photonics-for-AI which has different competitive dynamics; multiple SEC short-seller reports cited 2024–25 valuation concerns.

Verdict — Avoid: Organic quantum revenue is microscopic, headline growth is acquisition-driven, ATM dilution has been heavy. The other three pure-plays have cleaner stories.

ARQQ — Arqit Quantum

Architecture: Symmetric-encryption key generation as quantum-safe networking software, plus PQC algorithms. Not gate-model quantum hardware.

H1 FY 2026 (Oct 2025–March 2026): revenue $623,000 (vs $67K H1 FY25; vs $463K H2 FY25). 11 contracts in H1 FY26 (versus 7 in full FY25). Cash + equivalents ~$28.9 million — the smallest cash buffer of any name in this guide. Implied runway at ~$10–15M quarterly burn = ~6–9 months without a raise.

Verdict — Avoid: Revenue scale doesn't validate product-market fit after multiple years post-de-SPAC. High dilution risk in the next 6–9 months. ADR liquidity thin for Indian retail.

LAES — SEALSQ Corp

Architecture: Quantum-resilient (post-quantum) semiconductors + secure elements + TPMs. Not a quantum computer company — SEALSQ makes chips that resist future quantum-computer attacks.

Q1 2026: revenue ~$4.1 million (+>200% YoY) driven by Vault-IC secure elements + IC'ALPS consolidation + smart meter / PKI recurring streams. FY 2026 guide reaffirmed revenue growth +50% to +100% YoY. Cash + short-term investments >$525 million (boosted by $125M registered direct offering March 16, 2026). Quantum Fund expanded to $200 million — internal SEALSQ vehicle for quantum + PQC startup investments.

Product roadmap: QS7001 ("Quantum Shield") chip — first chip with hardware-embedded NIST PQC algorithms (ML-KEM + ML-DSA in silicon, ~10× perf gains). QS7001 V2 silicon fabrication targeted April 7, 2026; engineering samples July 2026. QVault TPM portfolio sampling November 2026. FIPS 203 (ML-KEM/Kyber) + FIPS 204 (ML-DSA/Dilithium) compliance; targeting Common Criteria EAL5+.

Verdict — Hedge: The cleanest pure-play public PQC chip exposure. NIST PQC adoption is the catalyst; cybersecurity incumbents adding PQC features is the bear case. Size 0.5% as PQC adoption call-option.

Layer 2 — Mega-cap embedded quantum (the more credible exposures)

IBM

Q1 2026 (reported April 22, 2026): revenue $15.92 billion (+9% YoY, beat consensus). EPS $1.91 (beat $1.81). FY 2026 guide: ≥5% constant-currency revenue growth; $1B+ FCF growth; software growth boosted to 10%+. Forward P/E ~22–24×.

Quantum roadmap — the most clearly articulated in the industry:

IBM Quantum Heron: 156-qubit superconducting processor — current production technology.
IBM Quantum System Two: Operational at Yorktown Heights, NY — 22ft × 12ft, three Heron processors, cryogenic + classical runtime co-located.
IBM Quantum Nighthawk: 120 qubits, square-lattice topology, 218 next-gen tunable couplers (>20% more connectivity than Heron), designed for 5,000 two-qubit gate workloads. Unveiled November 2025; designed to reach 7,500 gates by end of 2026 and scale across 3 modules to 360 qubits combined.
Loon processor: unveiled November 2025 alongside Nighthawk; focused on long-range qubit connectivity required for error correction.
Quantum advantage target: IBM expects to demonstrate quantum advantage by 2026 (verifiable problem instance).
IBM Quantum Starling — large-scale fault-tolerant target 2029: 200 logical qubits running 100 million quantum gates, built in Poughkeepsie, NY.
Blue Jay (post-2033): ~2,000 logical qubits, billion-gate-class operations.

DARPA QBI: IBM selected for Stage A and advanced to Stage B (one of 11 companies). Quantum Network customers: 250+ enterprise/government members (largest commercial quantum ecosystem) including JPMorgan, Boeing, ExxonMobil, multiple DOE labs.

Risk for quantum-as-IBM-thesis: Quantum is <0.5% of revenue; impossible to size; even if quantum doubles, IBM stock impact is negligible.

Verdict — Add (own for everything else, get quantum free): The most articulated quantum roadmap, largest enterprise quantum network, lowest valuation per quantum dollar invested. Buyers should own IBM for software + mainframe + consulting first; quantum is the embedded option.

GOOG / GOOGL — Alphabet (Google Quantum AI)

Q1 FY27 revenue and segment commentary covered in detail in the semi guide. Quantum activity is buried in Google DeepMind / Other Bets / R&D; not disclosed as a segment.

Willow chip (December 9, 2024): 105 qubits, superconducting, Santa Barbara fab. Published in Nature December 2024 — "Quantum error correction below the surface code threshold" (peer-reviewed). Achieved below-threshold quantum error correction — exponential error suppression as physical-qubit grid scales (3×3 → 5×5 → 7×7, error rate halved each step). RCS benchmark: 5 minutes for a task estimated to take leading classical supercomputer ~10^25 years (Random Circuit Sampling is synthetic).

Quantum Echoes (October 22, 2025) — the first verifiable quantum advantage:

Out-of-Time-Order Correlator (OTOC) algorithm running on Willow.
Published in Nature, October 22, 2025.
Runs 13,000× faster on Willow than the best classical algorithm on top supercomputers.
"Verifiable" = result reproducible across two quantum processors running in parallel — first time this property has been demonstrated.
Application demonstration: "molecular ruler" for NMR distance measurement.

DARPA QBI: Google Quantum AI joined Stage A in September 2025. QuEra (neutral atom) collaboration disclosed — Google-QuEra is part of the neutral-atom strategic thrust.

Forward P/E ~22–24× on aggregate Alphabet.

Verdict — Core buy (for everything else): Quantum Echoes is the strongest quantum-advantage result on the public record. But quantum is <0.1% of Alphabet revenue. Own GOOGL for search + cloud + DeepMind first.

MSFT — Microsoft (Azure Quantum)

Q3 FY26 (CQ1 2026) covered in the semi guide. Quantum not separately disclosed.

Majorana 1 chip (announced February 19, 2025): topological qubit approach using topoconductor material stack (indium arsenide + aluminum). Published in Nature February 2025. The paper attracted significant scientific debate about whether topological qubits had actually been demonstrated.

Majorana 2 chip (announced June 2, 2026 — the day before this article publishes):

Materials stack: aluminum replaced with lead in superconducting layer.
>2× topological gap versus Majorana 1.
1,000× reliability improvement versus Majorana 1.
Mean qubit lifetime 20 seconds; some instances up to 1 minute — very long by superconducting standards.
Developed using Microsoft Discovery agentic-AI research platform.
Timeline cut in half: Microsoft now expects scalable quantum computer by 2029 (originally late-2030s).

Partnerships: Azure Quantum hosts IonQ, Quantinuum, Rigetti, Pasqal, QCI hardware. Atom Computing strategic partnership for neutral-atom Phoenix system integration.

DARPA QBI: Microsoft not in the public Stage A or Stage B cohort lists (Atom Computing, Microsoft's neutral-atom partner, IS in Stage B).

Forward P/E ~32–35× FY27e.

Risk: Topological qubit thesis was widely doubted post-2021 retraction controversy (separate from current claims); single-chip qubit counts remain far behind superconducting and trapped-ion peers; quantum is <0.05% of revenue.

Verdict — Core buy (semi thesis, with Majorana 2 as upside): The Majorana 2 timeline pull-in to 2029 is the most material quantum-as-mega-cap event of 2026. Still <0.05% of Microsoft revenue. Own MSFT for everything else first.

AMZN — Amazon (AWS Center for Quantum Computing + Braket)

Ocelot chip (announced February 27, 2025):

Developed at AWS Center for Quantum Computing at Caltech.
"Cat qubits" — Schrödinger-cat encoding intrinsically suppresses bit-flip errors (only phase-flip needs correction).
Claimed ~90% reduction in error-correction resource cost versus conventional approaches.
Published in Nature February 2025 (peer-reviewed).
First-generation only — not yet scaled to user-facing service.

Amazon Braket: multi-vendor quantum cloud service — provides access to IonQ, Rigetti, IQM, QuEra, Oxford Quantum Circuits hardware. Cumulative customer base disclosed in low thousands as of 2024–25 commentary.

Forward P/E ~30–32×.

Verdict — Core buy (for AWS thesis): Ocelot's cat-qubit error-correction efficiency claim is novel. Amazon's quantum effort is research-stage; if commercial quantum becomes meaningful, AWS will likely buy/partner rather than scale Ocelot. Quantum <0.01% of revenue.

NVDA — NVIDIA (CUDA-Q + cuQuantum + NVQLink)

The market-shaping moment: At CES 2025 (January 7–8, 2025), Jensen Huang said practical quantum is 15–30 years away — "If you said 15 years for very useful quantum computers, that'd probably be on the early side… 20 years is a number that a lot of us would believe."

Same-day market reaction: IONQ −39%, RGTI −45%, QBTS −30%+, QUBT −20%+ in single sessions. Cohort lost >$830 million in market cap.

The walk-back: At NVIDIA GTC 2025 "Quantum Day" (March 20, 2025), Huang publicly admitted "my comments came out wrong" and reversed the timeline tone.

NVIDIA's actual quantum positioning (it is not a quantum-computer maker):

CUDA-Q: Open hybrid quantum-classical SDK for running quantum kernels on classical GPU simulators and dispatching to QPU back-ends.
cuQuantum: GPU-accelerated quantum-circuit simulation library.
NVQLink (publicly available at GTC 2026 via cudaq-realtime API): Real-time quantum-classical interconnect. 17 quantum-hardware builders + 9 national labs signed on at launch.
NVIDIA Accelerated Quantum Computing Research Center (Boston): Dedicated quantum-classical hybrid research facility (announced GTC 2025).

Forward P/E ~35–40× (detailed in semi guide).

Risk for "buying NVDA for quantum": Quantum exposure is <0.1%. The investment thesis is GPU/data-center. NVDA could be the biggest beneficiary if quantum stays years away — more GPU compute needed for hybrid workloads and simulation.

Verdict — Core buy (semi thesis): NVDA is the closest thing to a quantum-cycle-agnostic hedge — wins whether quantum arrives in 5 years or 25.

INTC — Intel (Tunnel Falls silicon spin qubit)

Architecture: Silicon spin qubits — fabricated on Intel's 300mm semiconductor manufacturing line using EUV.

Tunnel Falls: 12-qubit research chip; 95% yield across wafer; 24,000+ quantum-dot devices per wafer. Argonne National Laboratory + Intel deployed and operated the 12-qubit processor (results published in Nature Communications). Single-qubit gate fidelity >99.7% demonstrated in academic collaborations. T1 relaxation times in seconds (very long for solid-state); T2 coherence 100s of microseconds to >1 ms with isotopically purified silicon.

Strategic posture: Tunnel Falls is research-grade only — not a commercial product. Intel positions silicon-spin as the architecture that benefits most from existing CMOS manufacturing scale.

Verdict — Hold (semi turnaround thesis): Intel's 18A node ramp and turnaround dominate the stock thesis. Tunnel Falls is a free option on quantum hardware reaching fault tolerance via CMOS-scale manufacturing.

HON — Honeywell (Quantinuum — pending IPO this month)

Honeywell Q1 2026: revenue $9.1 billion (+2% YoY). Adjusted EPS $2.45 (+11% YoY). Segment margin 23.3% (+90 bps).

Quantinuum IPO status (as of June 2–4, 2026 — the days before this article publishes):

Confidential S-1 filing announced May 26, 2026.
June 1, 2026: IPO upsized — pricing range $53–55/share, 26.5 million shares, raising up to ~$1.46 billion.
Valuation target up to $14.3 billion.
Honeywell expected to retain ~49.1% voting power post-IPO; Cambridge Quantum Holdings ~32.5%; combined ~82% founder ownership post-IPO.
Honeywell will deconsolidate Quantinuum from HON financials in Q2 2026 post-IPO.

Quantinuum hardware: H-Series trapped-ion (from Cambridge Quantum + Honeywell Quantum Solutions merger November 2021). Prior funding: 2024 round $300M at $5B pre-money (JPMorgan, Mitsui, Amgen, Honeywell); 2026 round $600M at $10B pre-money.

DARPA QBI: Quantinuum is in Stage B cohort (November 2025) — one of 11 companies advancing. Notable benchmarks: Quantinuum's H-Series has held world-record quantum-volume scores in the trapped-ion category and demonstrated logical-qubit error rates below physical-qubit error rates (a key fault-tolerance milestone, published 2024).

Verdict on HON — Hold: Honeywell ceases to be a clean "quantum stock by proxy" after Q2 2026 deconsolidation. The quantum thesis migrates to the standalone Quantinuum ticker once it trades.

Verdict on Quantinuum (post-IPO) — Watch: Likely displaces IonQ as the trapped-ion anchor of the speculative leg of any quantum portfolio. Wait for two clean quarterly prints post-lockup (likely late 2026 / early 2027) before initiating. The IPO this month will be the single largest quantum-cohort sentiment event of the year.

HPE — Hewlett Packard Enterprise

DARPA QBI Stage A (April 2025); NOT in Stage B cohort (November 2025). HPE's quantum activity is primarily classical-quantum hybrid supercomputing integration. No HPE quantum-hardware product line.

Verdict — Skip (quantum thesis): Wrong wrapper for a quantum bet.

Layer 3 — Picks-and-shovels (cryogenics + photonics)

FORM — FormFactor

Q1 2026: revenue $226.1 million (+32.0% YoY) — record sequential increase. Drivers: Probe Cards for Foundry & Logic; record DRAM probe-card quarter (HBM driven); Smart Matrix adoption ramp.

Quantum role: FormFactor provides cryogenic probe systems used to characterize quantum devices at <1 Kelvin. Partners with Bluefors (Finnish cryostat leader) on integrated cryogenic test solutions. Q1 2026 commentary explicitly cited "increasingly important role in providing cryogenic infrastructure for quantum computing." CPO revenue 2026 guide $10–20 million high-end driven by Triton co-packaged-optics platform.

Verdict — Hold (semi thesis): Quantum + CPO is single-digit % of total revenue; HBM probe-card cycle is the actual driver. Buy for HBM; quantum is free option.

MKSI — MKS Instruments

Q1 2026: revenue $1.078 billion (+15% YoY, +4% sequentially). Non-GAAP EPS $2.30. Semiconductor segment $466 million (43% of total), +13% YoY. Vacuum systems + RF/plasma + sensors used in quantum chip fab and dilution refrigerator support. Not separately disclosed.

Verdict — Hold (semi thesis): Same as FORM — quantum is incidental.

COHR — Coherent

Fiscal Q3 2026 (CQ1 2026): revenue $1.81 billion (+21% YoY) — record. Non-GAAP gross margin 39.6%; non-GAAP diluted EPS $1.41. Datacenter segment +41% YoY, now 75% of revenue (AI optics drives the print). Lasers + photonic components used in trapped-ion / photonic / atomic quantum systems; quantum-secured communications announcements at OFC 2026.

Note: Coherent is the post-merger entity. II-VI completed its acquisition of legacy Coherent in 2022 and rebranded the combined company "Coherent Corp." The old II-VI / IIVI ticker is retired.

Verdict — Add (semi/AI optics thesis): AI optics is the actual thesis; quantum is incidental upside.

LITE — Lumentum

Fiscal Q2 2026: revenue $665.5 million (+66% YoY). Optical Circuit Switch backlog >$400 million; CPO backlog "multi-hundred-million" deliverable H1 2027. Photonic components used in quantum networking + fiber-based QKD; not separately disclosed.

Verdict — Add (semi/AI optics thesis): Same framing as COHR.

POET — POET Technologies

Q1 2026: revenue $503,000 NRE + product revenue. $400 million raised to scale integrated photonics for AI/hyperscale data centers. POET + Quantum Computing Inc. 3.2 Tbps optical engine co-development partnership. FY 2026 outlook: $50–125 million revenue range; targeting breakeven mid-to-late 2026.

Verdict — Skip: Multiple successive guidance resets historically; revenue base is microscopic versus valuation; "quantum" is incidental.

Layer 4 — Private leaders (the names you can't buy yet, plus the one IPO'ing this month)

The actual quantum leaders are mostly private. The public pure-play universe is missing the front-runners.

Quantinuum (Honeywell-backed) — IPO pricing window this month (June 2026) at up to $14.3 billion. Honeywell retains ~49.1% voting; deconsolidates Q2 2026. H-Series trapped-ion world-record holder; DARPA QBI Stage B.
PsiQuantum (private): $1 billion Series E September 2025 at ~$7 billion post-money — led by BlackRock; Temasek, Baillie Gifford participants; NVentures (NVIDIA VC) participating for first time. Silicon photonics architecture. $617 million Australia + Queensland government package for Brisbane fault-tolerant quantum computer (2024). Linde Engineering partnership (May 2025) to build one of the largest cryogenic plants ever for a quantum computer. No confirmed IPO filing as of June 2026.
QuEra (private): $507M+ raised; Google strategic investor; delivered error-correction-ready machine to AIST (Japan); in DARPA QBI Stage B.
Atom Computing (private): $200M+ raised; Microsoft strategic partner for Phoenix + Azure Quantum integration; first to cross the 1,000-qubit barrier (October 2023, 1,180 atoms); in DARPA QBI Stage B.
Pasqal, Xanadu, Photonic Inc., Diraq, Nord Quantique, Quantum Motion, Silicon Quantum Computing — all private; all in DARPA QBI Stage B except Pasqal (Stage A; not in Stage B cohort).

Verdict on Quantinuum (post-IPO) — Watch: Wait for two clean post-lockup quarterly prints. Once it trades, it's the most credible public trapped-ion exposure.

Verdict on PsiQuantum/QuEra/Atom Computing — N/A until IPO: Not investable by Indian retail via standard US-brokerage. Watch the calendar.

Layer 5 — Quantum-themed ETFs

QTUM — Defiance Quantum ETF

Underlying index: BlueStar Quantum Computing and Machine Learning Index.
Constituent rule: Stocks deriving ≥50% of annual revenue or operating activity from quantum computing and ML.
AUM (early 2026): >$3.6 billion.
Holdings: ~71–87 stocks (modified equal-weighted at rebalance, with liquidity adjustments).
Expense ratio: 0.40%.

Top holdings drift between rebalances (recent point-in-time): Micron Technology (MU) ~3.04%, Intel (INTC) ~2.57%, MediaTek (TW) ~2.53%, STMicroelectronics (STM) ~2.29%, Nokia Oyj (NOK) ~2.13%, Marvell Technology (MRVL) ~1.84% — followed by other semi + photonics + ML names.

Critical caveat: QTUM is mostly a semiconductor + ML ETF, not a pure quantum ETF. Pure-play quantum names (IONQ, RGTI, QBTS, QUBT) are present but at small weights given equal-weighting. This is actually a feature for survivability but should not be misrepresented as concentrated quantum exposure.

No second meaningful "quantum-pure" ETF as of June 2026.

Verdict — Add (the diversified active exposure): The most defensible way for retail to hold quantum optionality without betting on a single architecture. Read the holdings file before sizing.

What not to chase

The names that look like quantum plays in social media coverage but aren't:

QSI (Quantum-Si) — protein-sequencing platform company. Name overlap is misleading. Do NOT include in any quantum-computing thesis.
IIVI (II-VI) — delisted into Coherent merger 2022. Old tickers no longer trade. The combined company is COHR.
NUKK (Nukkleus), NXT-AI, NQMC — no verified meaningful quantum exposure. Avoid.
Cybersecurity incumbents (PANW, CRWD, NET, ZS, etc.) — adding PQC-ready features but PQC is a feature, not a thesis. Not quantum pure-plays.
THLS (Thales Group) — French-listed (Paris HO); quantum exposure via Thales Alenia Space (satellite QKD) + Thales DIS (secure elements). Not available in standard Indian-retail US-broker access — investors would need Euronext access.
ARQQ, PLUG-style speculative names — covered above; multiple raises with thin revenue scale.

Three positioning options

Quantum should be a small allocation for retail — likely 0–3% of equity portfolio at most. The case for 0% (pass entirely) is defensible because mega-caps already give exposure.

Option A — Pass (recommended for conservative investors)

Don't try to time quantum. Hold NVDA + MSFT + GOOG + AMZN + IBM as part of normal mega-cap weighting — quantum is embedded for free. Re-evaluate in 2028 when:

IBM Nighthawk 7,500-gate milestone tested
Quantinuum's first public year completes
Microsoft Majorana 2 progression provides more data points
Quantum advantage claims (Quantum Echoes-style) accumulate or fade

For most readers of this guide, this is the right answer.

Option B — ETF (the most-diversified active exposure)

QTUM (Defiance Quantum) at 1–3% portfolio weight. Caveats:

~$3.6 billion AUM, 0.40% fee.
70–87 holdings, mostly semiconductors + ML, not pure quantum.
This is a feature for survivability — single-architecture risk is hedged.
Indian retail access: NYSE Arca; broadly available on Vested / INDmoney / IBKR / Rovia.

Option C — Barbell (for investors who want concentrated quantum risk)

Bucket	Weight	Names
Anchor (own for everything else)	1.5%	IBM 1.5% — most articulated roadmap, largest enterprise quantum network
Speculative basket	1% max	IONQ 0.5%, QBTS 0.25%, LAES 0.25%

Post-Quantinuum-IPO consideration: once Quantinuum trades cleanly post-lockup (late 2026 / early 2027), it may displace IonQ as the trapped-ion anchor of the speculative leg.

Note: Do NOT increase the speculative basket above 1%. The Jensen Huang January 2025 episode (cohort −30 to −45% in a single session) is the volatility profile to size around.

The risk scenarios

Pre-revenue + dilution risk. Cash positions are large (IONQ $3.1B, RGTI $569M, QBTS $588M, QUBT $1.4B) but quarterly burn is also large. Dilution risk is the real risk, not insolvency: IONQ paid for Oxford Ionics + Lightsynq + Capella largely in IONQ stock — fully-diluted share count is ~50% higher than pre-2025. Arqit is the exception with ~6–9 month runway absent a raise.

Architecture risk. Seven competing architectures (superconducting, trapped-ion, photonic, neutral-atom, annealing, topological, silicon-spin) — one or more may not reach fault tolerance. A concentrated single-name bet is implicitly a bet on one architecture. QTUM ETF hedges architecture risk; single-name bets do not.

Mega-cap dilution. Buying IBM, GOOG, MSFT, AMZN, NVDA "for quantum" means buying everything else first. The semi guide established that the AI-infrastructure cycle is the actual thesis for those names.

Hype-vs-reality volatility. January 2025 Jensen comment caused IONQ −39%, RGTI −45%, QBTS −30%+ in a single session. Investors should expect 30–50% drawdowns at any sentiment shift. Quantinuum IPO trading may be a sentiment catalyst either direction.

Public is missing the actual leaders. Top trapped-ion = Quantinuum (IPO this month). Top photonic = PsiQuantum (private). Top neutral-atom = QuEra + Atom Computing (private). Top superconducting research effort = Google Willow (not investable as pure-play). The public pure-play universe is structurally missing the front-runners.

Customer concentration. Commercial recurring revenue is essentially zero across the cohort except for D-Wave's QCaaS contracts. Government / academic / pilot dominates revenue.

How an Indian-resident investor actually executes this

The platform map. All US-listed quantum names (IONQ, RGTI, QBTS, QUBT, LAES, IBM, GOOG, MSFT, AMZN, NVDA, INTC, HON, FORM, MKSI, COHR, LITE, POET, QTUM) — broadly accessible on Vested / INDmoney / IBKR / Rovia. Arqit (ARQQ) — available as ADR but thin liquidity, check spreads before sizing. Quantinuum (post-IPO) — NASDAQ pending; expect availability within standard IPO trading windows. PsiQuantum, QuEra, Atom Computing, Pasqal — private, not accessible. Thales (Paris HO) — requires Euronext access; not standard Indian retail.

Platform cost comparison in Vested vs INDmoney vs IBKR vs Rovia.

Tax on gains. Foreign equity LTCG 12.5% under Section 112 with a 24-month holding period. STCG = slab. Indexation removed for foreign equity post-Budget 2024.

Schedule FA. Any of these names held at any point during the calendar year (January–December) triggers a Schedule FA disclosure obligation. See the Schedule FA disclosure guide.

Dividend withholding. US default 25% under DTAA (no further reduction). Most quantum pure-plays do not pay dividends. IBM (3–4% yield), NVDA / GOOG / AMZN / MSFT (low-single-digit) do.

Currency exposure. Long USD against the rupee. The 24-month LTCG holding period locks in that currency exposure.

The closing

The honest read on June 2026:

The Quantinuum IPO pricing this week and the Majorana 2 announcement on June 2 are the two most material quantum-as-mega-cap events of the year. Both happened in 48 hours.
Four public pure-plays combined did ~$76 million of Q1 2026 revenue at >$40 billion aggregate market cap. This is the most speculative thematic of the five 2026 guides.
Rigetti was not in the DARPA QBI Stage B cohort while IonQ, Quantinuum, IBM, QuEra, Atom Computing advanced. That is the cleanest single-data-point relative signal in the public pure-play universe.
The actual quantum leaders are mostly private (PsiQuantum, QuEra, Atom Computing) — public pure-plays are missing the front-runners.
Mega-caps embed quantum at <1% of revenue. Buying them "for quantum" means buying everything else first.
QSI is protein sequencing, not quantum computing. IIVI is delisted into COHR. NUKK / NXT-AI / NQMC don't have meaningful quantum exposure. The misleading branding is real.
The case for owning nothing is defensible. Mega-cap exposure is sufficient for most readers.

The 2024–25 thematic playbook was "buy IONQ, RGTI, QBTS into the Willow announcement, sell into the Jensen comment, re-buy on the walk-back." That worked once. It's a trading pattern, not an investment thesis.

The 2026 thesis is more specific: own NVDA + MSFT + GOOG + AMZN + IBM as part of normal mega-cap weighting and let quantum embed itself; if you must take active quantum exposure, QTUM ETF for diversified architecture exposure, or a 1.5% IBM anchor plus a strict 1% maximum speculative basket; wait for Quantinuum to print two clean public quarters before considering it; pass on Rigetti until the DARPA Stage B exclusion is reversed.

The press releases will continue to dominate the headlines.

The peer-reviewed papers are where the actual progress lives — and as of June 2026, the most consequential is Google Quantum Echoes, not anything in a public pure-play S-1.